{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:14:25Z","timestamp":1792134865643,"version":"4.4.0"},"reference-count":38,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.2967\/jnumed.123.266254","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T08:55:22Z","timestamp":1706777722000},"page":"178-184","source":"Crossref","is-referenced-by-count":46,"title":["Phase II Trial Assessing the Repeatability and Tumor Uptake of [\n                    <sup>68<\/sup>\n                    Ga]Ga-HER2 Single-Domain Antibody PET\/CT in Patients with Breast Carcinoma"],"prefix":"10.2967","volume":"65","author":[{"given":"Odrade","family":"Gondry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Caveliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Raes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Vanhoeij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Verfaillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Glorieus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"De Gr\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Joris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Zwaenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Vandenbroucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Waelput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeno","family":"Thyparambil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vaneycken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Cousaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Devoogdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"De Geeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lahoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Keyaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2024020105551735000_65.2.178.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2024020105551735000_65.2.178.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101"},{"key":"2024020105551735000_65.2.178.3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3322\/caac.21705","article-title":"Antibody-drug conjugates: smart chemotherapy delivery across tumor histologies","volume":"72","author":"Tarantino","year":"2022","journal-title":"CA Cancer J Clin."},{"key":"2024020105551735000_65.2.178.4","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1002\/cncr.33102","article-title":"Novel HER2-targeted therapies for HER2-positive metastatic breast cancer","volume":"126","author":"Kunte","year":"2020","journal-title":"Cancer."},{"key":"2024020105551735000_65.2.178.5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13058-021-01459-y","article-title":"Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions","volume":"23","author":"Ferraro","year":"2021","journal-title":"Breast Cancer Res."},{"key":"2024020105551735000_65.2.178.6","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.1993.11.10.1936","article-title":"Clinical significance of HER-2\/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group","volume":"11","author":"Seshadri","year":"1993","journal-title":"J Clin Oncol."},{"key":"2024020105551735000_65.2.178.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203690"},{"key":"2024020105551735000_65.2.178.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8738"},{"key":"2024020105551735000_65.2.178.9","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.ctrv.2021.102286","article-title":"Targeting HER2 heterogeneity in breast cancer","volume":"100","author":"Hamilton","year":"2021","journal-title":"Cancer Treat Rev."},{"key":"2024020105551735000_65.2.178.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265434"},{"key":"2024020105551735000_65.2.178.11","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32833f8c3a"},{"key":"2024020105551735000_65.2.178.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8448"},{"key":"2024020105551735000_65.2.178.13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00259-020-05094-1","article-title":"HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging","volume":"48","author":"Altunay","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024020105551735000_65.2.178.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705915"},{"key":"2024020105551735000_65.2.178.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.162024"},{"key":"2024020105551735000_65.2.178.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.111021"},{"key":"2024020105551735000_65.2.178.17","doi-asserted-by":"crossref","first-page":"632687","DOI":"10.3389\/fimmu.2021.632687","article-title":"Immunogenicity risk profile of nanobodies","volume":"12","author":"Ackaert","year":"2021","journal-title":"Front Immunol."},{"key":"2024020105551735000_65.2.178.18","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/7.9.1129"},{"key":"2024020105551735000_65.2.178.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186353"},{"key":"2024020105551735000_65.2.178.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.06.002"},{"key":"2024020105551735000_65.2.178.21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-180331"},{"key":"2024020105551735000_65.2.178.22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11307-018-01302-5","article-title":"Clinical translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET\/CT imaging of protumorigenic macrophages","volume":"21","author":"Xavier","year":"2019","journal-title":"Mol Imaging Biol."},{"key":"2024020105551735000_65.2.178.23","doi-asserted-by":"crossref","first-page":"P4-11-29","DOI":"10.1158\/1538-7445.SABCS14-P4-11-29","article-title":"Quantitative measurement of HER2 levels by multiplexed mass spectrometry from FFPE tissue predicts survival in patients treated with anti-HER2 based therapy [abstract]","volume":"75","author":"Nuciforo","year":"2015","journal-title":"Cancer Res"},{"key":"2024020105551735000_65.2.178.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1402"},{"key":"2024020105551735000_65.2.178.25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41523-021-00343-4","article-title":"Evolution of HER2-low expression from primary to recurrent breast cancer","volume":"7","author":"Miglietta","year":"2021","journal-title":"NPJ Breast Cancer."},{"key":"2024020105551735000_65.2.178.26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.7239","article-title":"Examination of low ERBB2 protein expression in breast cancer tissue","volume":"8","author":"Fernandez","year":"2022","journal-title":"JAMA Oncol."},{"key":"2024020105551735000_65.2.178.27","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2016.1192"},{"key":"2024020105551735000_65.2.178.28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv577"},{"key":"2024020105551735000_65.2.178.29","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.2967\/jnumed.115.157941","article-title":"Imaging diagnostic and therapeutic targets: human epidermal growth factor receptor 2","volume":"57(suppl 1)","author":"Gebhart","year":"2016","journal-title":"J Nucl Med."},{"key":"2024020105551735000_65.2.178.30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41374-022-00804-9","article-title":"Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer","volume":"102","author":"Moutafi","year":"2022","journal-title":"Lab Invest."},{"key":"2024020105551735000_65.2.178.31","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2967\/jnumed.119.236083","article-title":"Quantitative test\u2013retest measurement of 68Ga-PSMA-HBED-CC in tumor and normal tissue","volume":"61","author":"Pollard","year":"2020","journal-title":"J Nucl Med."},{"key":"2024020105551735000_65.2.178.32","doi-asserted-by":"publisher","DOI":"10.7150\/thno.13502"},{"key":"2024020105551735000_65.2.178.33","doi-asserted-by":"crossref","first-page":"834651","DOI":"10.3389\/fmolb.2022.834651","article-title":"HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer","volume":"9","author":"Venetis","year":"2022","journal-title":"Front Mol Biosci."},{"key":"2024020105551735000_65.2.178.34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13058-020-1252-7","article-title":"HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates","volume":"22","author":"Oca\u00f1a","year":"2020","journal-title":"Breast Cancer Res."},{"key":"2024020105551735000_65.2.178.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.100354"},{"key":"2024020105551735000_65.2.178.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2712-0"},{"key":"2024020105551735000_65.2.178.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265364"},{"key":"2024020105551735000_65.2.178.38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-018-4696-z","article-title":"Evaluation of [89Zr]trastuzumab-PET\/CT in differentiating HER2-positive from HER2-negative breast cancer","volume":"169","author":"Dehdashti","year":"2018","journal-title":"Breast Cancer Res Treat."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.266254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T08:58:25Z","timestamp":1706777905000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.266254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.2967\/jnumed.123.266254"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.266254","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}